alligator bioscience Alligator Bioscience hires Chief Financial Officer in interim capacity By www.pharmafile.com Published On :: Mon, 09 Mar 2020 17:21:44 +0000 Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it was previously confirmed will no longer serve the company. Johannesson’s career has spanned 15 years in the consumer goods sector, with him managing the finances of firms including TeamOlmed, Stenqvist, Fitness23Seven and Haldex. He spent a further nine years of his career as a strategic consultant with a focus on consumer goods, five of which were spent at global consulting firm McKinsey & Company. read more Full Article Alligator Bioscience pharma Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
